Impact of transdermal fentanyl on quality of life in rheumatoid arthritis

Clinical Journal of Pain

Volumn 23, Issue 6, 2007, Pages 530-534

  Berliner, Michael N ^a,c   Giesecke, Thorsten ^b   Bornhövd, Karin D ^b  

^a HUMBOLDT UNIVERSITY   (Germany)

^b JANSSEN CILAG GMBH   (Germany)

^c HELIOS KLINIKUM BERLIN BUCH   (Germany)

Author keywords

Noncancer pain; Quality of life; Rheumatoid arthritis; Transdermal fentanyl

Indexed keywords

ANTIRHEUMATIC AGENT; AZATHIOPRINE; BUPRENORPHINE; CYCLOSPORIN A; FENTANYL; GLUCOCORTICOID; GOLD; METHOTREXATE; MORPHINE; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE; OXYCODONE; TRAMADOL;

ADULT; AGED; ANOREXIA; ARTICLE; BLOOD PRESSURE; CLINICAL TRIAL; CONSTIPATION; CRYOTHERAPY; DIZZINESS; DRUG DOSE INCREASE; DRUG TOLERABILITY; DRUG WITHDRAWAL; FEMALE; FUNCTIONAL DISEASE; HEART RATE; HUMAN; KINESIOTHERAPY; MAJOR CLINICAL STUDY; MALE; NAUSEA; OCCUPATIONAL THERAPY; PAIN; PAIN ASSESSMENT; PATIENT COMPLIANCE; PATIENT SATISFACTION; PHYSIOTHERAPY; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; RATING SCALE; RHEUMATOID ARTHRITIS; SEDATION; SIDE EFFECT; SLEEP; SOCIAL STATUS; VERTIGO; VOMITING; WELLBEING;

ACTIVITIES OF DAILY LIVING; ADMINISTRATION, CUTANEOUS; ADULT; AGED; AGED, 80 AND OVER; ANALGESICS, OPIOID; ANTI-INFLAMMATORY AGENTS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ARTHRITIS, RHEUMATOID; FEMALE; FENTANYL; HUMANS; MALE; MIDDLE AGED; PAIN; PAIN MEASUREMENT; PHYSICAL THERAPY MODALITIES; PROSPECTIVE STUDIES; QUESTIONNAIRES; SLEEP;

EID: 34250783237     PISSN: 07498047     EISSN: None     Source Type: Journal    
DOI: 10.1097/AJP.0b013e318074c9b1     Document Type: Article

References (22)

1. Badley EM, Tennant A. Impact of disablement due to rheumatic disorders in a British population: estimates of severity and prevalence from the Calderdale Rheumatic Disablement Survey. Ann Rheum Dis. 1993;52:6-13.
2. Scott DL, Shipley M, Dawson A, et al. The clinical management of rheumatoid arthritis and osteoarthritis: strategies for improving clinical effectiveness. Br J Rheumatol. 1998;37:546-554.
3. Wiech K, Preissl H, Birbaumer N. Neuroimaging of chronic pain: phantom limb and musculoskeletal pain. Scand J Rheumatol Suppl. 2000;113:13-18.
4. Lee C, Straus WL, Balshaw R, et al. A comparison of the efficacy and safety of nonsteroidal antiinflammatory agents versus acetaminophen in the treatment of osteoarthritis: a meta-analysis. Arthritis Rheum. 2004;51:746-754.
5. Lichtenstein DR, Syngal S, Wolfe MM. Nonsteroidal antiinflammatory drugs and the gastrointestinal tract. The double-edged sword. Arthritis Rheum. 1995;38:5-18.
6. Singh G, Rosen RD. NSAID induced gastrointestinal complications: the ARAMIS perspective-1997. Arthritis, Rheumatism, and Aging Medical Information System. J Rheumatol Suppl. 1998;51: 8-16.
7. Palmer BF. Renal complications associated with use of nonsteroidal anti-inflammatory agents. J Investig Med. 1995;43:516-533.
8. Ytterberg SR, Mahowald ML, Woods SR. Codeine and oxycodone use in patients with chronic rheumatic disease pain. Arthritis Rheum. 1998;41:1603-1612.
9. Vlak T. Tramadol (Tramal) in the treatment of rheumatic diseases-comparative study. Reumatizam. 1996;43:1-10.
10. Moran C. MST continuous tablets and pain control in severe rheumatoid arthritis. Br J Clin Res. 1991;2:1-12.
11. Muijsers RB, Wagstaff AJ. Transdermal fentanyl: an updated review of its pharmacological properties and therapeutic efficacy in chronic cancer pain control. Drugs. 2001;61:2289-2307.
12. Ringe JD, Faber H, Bock O, et al. Transdermal fentanyl for the treatment of back pain caused by vertebral osteoporosis. Rheumatol Int. 2002;22:199-203.
13. Simpson RK Jr, Edmondson EA, Constant CF, et al. Transdermal fentanyl as treatment for chronic low back pain. J Pain Symptom Manage. 1997;14:218-224.
14. Arnett FC, Edworthy SM, Bloch DA, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 1988;31:315-324.
15. Steinbrocker O, Träger CH, Battermann RC. Therapeutic criteria in rheumatoid arthritis. JAMA. 1949;140:659-662
16. Basler HD. The Marburg questionnaire on habitual health findings - a study on patients with chronic pain. Schmerz. 1999; 13:385-391.
17. Zimmermann M. Management of patients with chronic pain syndromes - deficits and perspectives. Schmerz. 2001;15:85-91.
18. Theodoridis T, Waap I, Schwalen S, et al. Fentanyl-TTS in the treatment of pain caused by arthrosis. Z Orthop Ihre Grenzgeb. 2003;141:217-222.
19. Allan L, Hays H, Jensen NH, et al. Randomised crossover trial of transdermal fentanyl and sustained release oral morphine for treating chronic non-cancer pain. BMJ. 2001;322:1154-1158.
20. Kalso E, Edwards JE, Moore RA, et al. Opioids in chronic noncancer pain: systematic review of efficacy and safety. Pain. 2004;112: 372-380.
21. Grond S, Radbruch L, Lehmann KA. Clinical pharmacokinetics of transdermal opioids: focus on transdermal fentanyl. Clin Pharmacokinet. 2000;38:59-89.
22. Pavelka K, Le LX, Bjorneboe O, et al. Benefits of transdermal fentanyl in patients with rheumatoid arthritis or with osteoarthritis of the knee or hip: an open-label study to assess pain control. Curr Med Res Opin. 2004;20:1967-1977.